Anthera Pharmaceuticals, Inc. Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ANTH and buy or sell other stocks, ETFs, and their options commission-free!About ANTH
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy.
CEOJohn Craig Thompson, MBA
CEOJohn Craig Thompson, MBA
Employees21
Employees21
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2004
Founded2004
Employees21
Employees21
ANTH Key Statistics
Market cap2.62K
Market cap2.62K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume45.30
Average volume45.30
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.001
52 Week high$0.001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 2.62K, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) trades at $0.00.
On 2026-04-24, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Anthera Pharmaceuticals, Inc. Common Stock(ANTH) stock has reached 0, versus its average volume of 45.3.
Over the past 52 weeks, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) stock has traded between a high of $0.00 and a low of $0.00.
Over the past 52 weeks, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) stock has traded between a high of $0.00 and a low of $0.00.